Crossborder co-development of
4D Engineered ECM technology
for regenerative therapies.
The E²CM project carries out research
in the field of regenerative medicine
and is supported by European Union.
E²CM partners ReGenesys,
IME Technologies and Antleron
target cells and biomaterials to be transformed via electrospinning,

3D printing and bioreactors

into a tissue engineered product.